- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06832436
Atrial Strain in Septic Shock (ALARMS)
January 15, 2026 updated by: Centre Hospitalier Universitaire, Amiens
Assessment of Left And Right Atrial Strain in Septic Shock
Septic shock is a critical condition associated with high mortality.
Transthoracic echocardiography is widely used to evaluate cardiac function and guide treatment.
Left and right atrial strain (LAS and RAS) measured via speckle tracking echocardiography have shown prognostic value in cardiovascular diseases.
However, differences exist between echocardiographic software, leading to challenges in result comparability.
This study aims to compare LAS and RAS measurements between ECHOPAC and UWS software, evaluate AutoStrain technology, and assess reproducibility across observers.
The study is non-interventional and will use retrospective echocardiographic data from patients treated for septic shock.
The findings will contribute to improving measurement standardization in critically ill patients.
Study Overview
Status
Recruiting
Study Type
Observational
Enrollment (Estimated)
60
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Christophe Beyls, MD
- Phone Number: 33+322087866
- Email: beyls.christophe@chu-amiens.fr
Study Locations
-
-
-
Salouël, France, 80480
- Recruiting
- CHRU Amiens
-
Contact:
- Christophe Beyls, MD
- Phone Number: 33 + 03 22 08 78 66
- Email: beyls.christophe@chu-amiens.fr
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Sampling Method
Non-Probability Sample
Study Population
Adult patients admitted to critical care for septic shock (SEPSIS-3 definition)
Description
Inclusion Criteria:
- Age: >18 years
- Adult patients admitted to critical care for septic shock (SEPSIS-3 definition)
- TTE performed as part of medical management
- No objection to data usage
Exclusion Criteria:
- Pregnancy
- Moderate to severe valvular regurgitation/stenosis (>grade 2)
- Ventricular or supraventricular tachyarrhythmia (HR >140 bpm) at the time of TTE
- Poor echogenicity preventing LAS measurement
- Mechanical circulatory support
- Pacemaker dependence
- Patients under guardianship
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
variation of LASr between ECOPAC and UWS
Time Frame: 1 year
|
Agreement of LAS Reservoir Phase (LASr) measurement in manual mode between ECHOPAC and UWS
|
1 year
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
variation of LAScd between ECHOPAC and UWS
Time Frame: 1 year
|
Comparison of LAS Conduit (LAScd) measurements in manual mode between ECHOPAC and UWS
|
1 year
|
|
variation of LASct between ECHOPAC and UWS
Time Frame: 1 year
|
Comparison of LAS Conduit (LAScd) and Contraction (LASct) measurements in manual mode between ECHOPAC and UWS
|
1 year
|
|
Comparison of LASr measurements in apical 2-chamber views
Time Frame: 1 year
|
Comparison of LASr measurements in apical 2-chamber views in manual mode between ECHOPAC and UWS
|
1 year
|
|
Comparison of LAScd measurements in apical 2-chamber views
Time Frame: 1 year
|
Comparison of LAScd measurements in apical 2-chamber views in manual mode between ECHOPAC and UWS
|
1 year
|
|
Comparison of LASct measurements in apical 2-chamber views
Time Frame: 1 year
|
Comparison of LASct measurements in apical 2-chamber views in manual mode between ECHOPAC and UWS
|
1 year
|
|
Comparison of right atrial strain RASr between ECHOPAC and UWS
Time Frame: 1 year
|
Comparison of right atrial strain (RASr) in manual mode between ECHOPAC and UWS
|
1 year
|
|
Comparison of right atrial strain RAScd between ECHOPAC and UWS
Time Frame: 1 year
|
Comparison of right atrial strain RAScd in manual mode between ECHOPAC and UWS
|
1 year
|
|
Comparison of right atrial strain RASct between ECHOPAC and UWS
Time Frame: 1 year
|
Comparison of right atrial strain RASct in manual mode between ECHOPAC and UWS
|
1 year
|
|
Comparison of LAS in AutoStrain versus manual mode
Time Frame: 1 year
|
Comparison of LAS measurements in AutoStrain versus manual mode on UWS
|
1 year
|
|
Comparison of RAS in AutoStrain versus manual mode
Time Frame: 1 year
|
Comparison of RAS measurements in AutoStrain versus manual mode on UWS
|
1 year
|
|
Comparison of LAS measurements in AutoStrain (UWS) versus manual mode on ECHOPAC
Time Frame: 1 year
|
Comparison of LAS measurements in AutoStrain (UWS) versus manual mode on ECHOPAC
|
1 year
|
|
Comparison of RAS measurements in AutoStrain (UWS) versus manual mode on ECHOPAC
Time Frame: 1 year
|
Comparison of RAS measurements in AutoStrain (UWS) versus manual mode on ECHOPAC
|
1 year
|
|
Assessment of differences in LAS measurements at end-diastole between ECHOPAC and UWS
Time Frame: 1 year
|
Assessment of differences in LAS phase measurements between ECHOPAC and UWS
|
1 year
|
|
Assessment of differences in LAS measurements at pre-A between ECHOPAC and UWS
Time Frame: 1 year
|
Assessment of differences in LAS measurements at pre-A between ECHOPAC and UWS
|
1 year
|
|
Assessment of differences in RAS measurements at end-diastole between ECHOPAC and UWS
Time Frame: 1 year
|
Assessment of differences in RAS measurements at end-diastole between ECHOPAC and UWS
|
1 year
|
|
Assessment of differences in RAS measurements at pre-A between between ECHOPAC and UWS
Time Frame: 1 year
|
Assessment of differences in RAS measurements at pre-A between between ECHOPAC and UWS
|
1 year
|
|
Inter-observer reproducibility assessment of manual measurements (UWS and GE) in a sample of 10 patients
Time Frame: 1 year
|
Inter-observer reproducibility assessment of manual measurements (UWS and GE) in a sample of 10 patients
|
1 year
|
|
Intra-observer reproducibility assessment of manual measurements (UWS and GE) in a sample of 10 patients
Time Frame: 1 year
|
Intra-observer reproducibility assessment of manual measurements (UWS and GE) in a sample of 10 patients
|
1 year
|
|
Inter-observer reproducibility assessment of AutoStrain measurements (UWS and GE) in a sample of 10 patients
Time Frame: 1 year
|
Inter-observer reproducibility assessment of AutoStrain measurements (UWS and GE) in a sample of 10 patients
|
1 year
|
|
Intra-observer reproducibility assessment of AutoStrain measurements (UWS and GE) in a sample of 10 patients
Time Frame: 1 year
|
Intra-observer reproducibility assessment of AutoStrain measurements (UWS and GE) in a sample of 10 patients
|
1 year
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Collaborators
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
March 6, 2025
Primary Completion (Estimated)
September 1, 2026
Study Completion (Estimated)
September 1, 2026
Study Registration Dates
First Submitted
February 11, 2025
First Submitted That Met QC Criteria
February 11, 2025
First Posted (Actual)
February 18, 2025
Study Record Updates
Last Update Posted (Estimated)
January 16, 2026
Last Update Submitted That Met QC Criteria
January 15, 2026
Last Verified
January 1, 2026
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- PI2025_843_0034
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Septic Shock
-
German Center for Neurodegenerative Diseases (DZNE)University Hospital, BonnUnknownSevere Sepsis With Septic Shock | Severe Sepsis Without Septic ShockGermany
-
Artcline GmbHRecruitingSepsis | Septic Shock | Immunoparalysis in Septic ShockGermany
-
Assistance Publique - Hôpitaux de ParisCompletedSeptic Shock HyperdynamicFrance
-
Laiba QamarRecruitingSeptic Shock | Fluid Refractory Septic ShockPakistan
-
University Medicine GreifswaldUnknownSepsis Septic ShockGermany
-
Indonesia UniversityCompletedSevere Sepsis With Septic Shock | Severe Sepsis Without Septic ShockIndonesia
-
University of ZurichCompletedPatients in Septic ShockSwitzerland
-
Centre Hospitalier Universitaire DijonCompleted
-
Mansoura UniversityCompleted
-
Rennes University HospitalTerminated